Tempus AI Surges, Flirting With A Profit-Taking Zone, On A Fresh FDA Move

BREAKING: Core CPI Steady, Jobless Claims Highest Since Oct. 2021Tempus AI (TEM) stock jumped into a profit-taking zone Thursday after the Food and Drug Administration cleared its updated cardiac-imaging platform, Tempus Pixel.The platform uses artificial intelligence to view cardiac magnetic resonance images, or MRI. Unlike conventional MR images that only show brightness differences, Tempus Pixel's maps provide precise numerical values to cardiac tissue characteristics. This helps clinicians detect condit ...